These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
99 related articles for article (PubMed ID: 14835492)
1. [Comparative clinical examination of the therapeutic effect of some new tetraalkylpyprophosphates in myasthenia gravis pseudoparalytical]. KOELZER PP; GIESEN J Ther Umsch Med Bibliogr; 1951 Feb; 7(11):172-82. PubMed ID: 14835492 [No Abstract] [Full Text] [Related]
2. [Myasthenia gravis therapy with SK 52]. GIESEN J; KOELZER PP Med Klin; 1950 Dec; 45(48):1530-1. PubMed ID: 14805958 [No Abstract] [Full Text] [Related]
3. Octamethyl pyrophosphoramide in treatment of myasthenia gravis: further observations. SCHULMAN S; RIDER JA; RICHTER RB AMA Arch Neurol Psychiatry; 1953 May; 69(5):643-6. PubMed ID: 13039628 [No Abstract] [Full Text] [Related]
4. The hazard of cholinergic crisis during treatment of myasthenia gravis with octamethyl pyrophosphoramide. WILSON CW; WILLIAMS JP; MILLER DH Ann Intern Med; 1952 Sep; 37(3):574-9. PubMed ID: 12976955 [No Abstract] [Full Text] [Related]
5. Octamethyl pyrophosphoramide in the therapy of myasthenia gravis. GREGORY L; FUTCH ED; STONE CT Am J Med; 1952 Oct; 13(4):423-7. PubMed ID: 12985599 [No Abstract] [Full Text] [Related]
6. Treatment of myasthenia gravis with octamethyl pyrophosphoramide; preliminary report. RIDER JA; SCHULMAN S; RICHTER RB; MOELLER HC; DUBOIS KP J Am Med Assoc; 1951 Mar; 145(13):967-72. PubMed ID: 14803293 [No Abstract] [Full Text] [Related]
7. Use of octamethyl pyrophosphoramide in the treatment of myasthenia gravis; further observations. SCHULMAN S; RIDER A; RICHTER RB J Am Med Assoc; 1953 Aug; 152(18):1707-11. PubMed ID: 13069246 [No Abstract] [Full Text] [Related]
8. [Experience in therapy of myasthenia with tetraisopropyl pyrophosphate (myastenol)]. MOLINA ; GOTZE W Arztl Wochensch; 1952 Dec; 7(50):1186-7. PubMed ID: 13016389 [No Abstract] [Full Text] [Related]
9. [Tetra-ethyl-pyrophosphate in the treatment of myasthenia; study of blood cholinesterase]. PASSOUANT P; LEVY A Rev Neurol (Paris); 1951 Jan; 84(1):88-91. PubMed ID: 14845372 [No Abstract] [Full Text] [Related]
14. [Rarely observed signs of fatigue in myasthenia gravis pseudoparalytica; origin of curare like substances in myasthenia]. GROSSE-BROCKHOFF F; WELTE E Dtsch Med Wochenschr; 1950 May; 75(21):698-700. PubMed ID: 15427509 [No Abstract] [Full Text] [Related]
15. Some physiological experiments of nature in the field of neuromuscular function; tetra-ethyl pyrophosphate in the treatment of myasthenia gravis, potassium deficiency, potassium intoxication. HARVEY AM Proc Inst Med Chic; 1948 Nov; 17(8):182-8. PubMed ID: 18892688 [No Abstract] [Full Text] [Related]
16. [Pseudoparalytical myasthenia gravis. Current position]. Yáñez Polo MA Rev Clin Esp; 1969 Nov; 115(4):261-70. PubMed ID: 5379539 [No Abstract] [Full Text] [Related]
17. [Cholinergic crisis in the treatment of myasthenia gravis]. KUNTZ E; KAUFMANN L Nervenarzt; 1954 May; 25(5):209-11. PubMed ID: 13194075 [No Abstract] [Full Text] [Related]
18. Successful use of sugammadex for caesarean section in a patient with myasthenia gravis. Soyoral L; Goktas U; Cegin MB; Baydi V Braz J Anesthesiol; 2017; 67(2):221-222. PubMed ID: 28236874 [TBL] [Abstract][Full Text] [Related]